Insider trades
DSS, 10% Owner of Impact Biomedical IBO, has filed 4 purchases and 19 sales on the open market. Over the past 12 months that comes to a net sale of $1,686. The latest trade was on 09/24.
DSS
10% Owner
- Company
- Impact Biomedical IBO
- First filing
- 23/05/08
- Trades
- 30 trades
- Buys / sales
- 4 / 19
- 12-month net buying
- −$1,686
- Last trade
- 09/24
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 09/22–09/24 | 09/24 | 906 sh3 trades | $1.86avg. | $1,686.46 | −0.2% | |
| Open-market sale | 25/05/22–25/05/27 | 01/06 | 161,000 sh2 trades | $0.55avg. | $88,096 | −22.8% | |
| Open-market sale | 25/05/22–25/05/27 | 25/05/27 | 161,000 sh2 trades | $0.55avg. | $88,096 | −100.0% | |
| Open-market sale | 25/04/04 | 25/04/07 | 890,800 sh | $0.95 | $846,260 | −84.7% | |
| Open-market sale | 25/03/21–25/03/27 | 25/03/28 | 605,620 sh6 trades | $3.22avg. | $1,950,714.73 | No record | |
| Open-market buy | 25/03/20 | 25/03/24 | 200 sh | $1.55 | $310 | +0.4% | |
| Open-market sale | 24/12/02–25/03/20 | 25/03/24 | 53,300 sh2 trades | $4.68avg. | $249,408.4 | −100.0% | |
| Open-market sale | 24/11/12–24/11/18 | 24/11/22 | 5,700 sh3 trades | $2.99avg. | $17,040 | −9.7% | |
| Open-market buy | 24/09/18 | 24/09/19 | 1,000 sh | $2.33 | $2,330 | +1.7% | |
| Open-market buy | 24/09/16–24/09/17 | 24/09/18 | 57,800 sh2 trades | $2.65avg. | $153,220 | No record |